Explore more publications!
West Virginia Healthcare Press
Got News to Share?

West Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on West Virginia Healthcare Press.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 20, 2025

Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress 2025
October 20, 2025

Primary Endpoint Met in EFTISARC-NEO Phase II Evaluating Neoadjuvant Efti in Soft Tissue Sarcoma and Data Presented at ESMO Congress 2025

Indeterminate GlobeNewswire
R1 Announces Strategic Partnership with Sierra to Revolutionize AI-Driven Experiences in Healthcare
October 20, 2025

R1 Announces Strategic Partnership with Sierra to Revolutionize AI-Driven Experiences in Healthcare

Indeterminate GlobeNewswire
ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
October 20, 2025

ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025

Indeterminate GlobeNewswire
BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.
October 20, 2025

BioNexus Gene Lab Corp Signs Strategic Partnership Term Sheet with BirchBioMed Inc.

Indeterminate GlobeNewswire
Phathom Pharmaceuticals to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, October 30, 2025
October 20, 2025

Phathom Pharmaceuticals to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, October 30, 2025

Indeterminate GlobeNewswire
Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs
October 20, 2025

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

Indeterminate GlobeNewswire
Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference
October 20, 2025

Galectin Therapeutics to Present at the H.C. Wainwright 9th Annual MASH Investor Conference

Indeterminate GlobeNewswire
Adaptyx Raises $14M in Seed Financing to Launch Wearable Platform for Continuous Multi-Analyte Molecular Monitoring
October 20, 2025

Adaptyx Raises $14M in Seed Financing to Launch Wearable Platform for Continuous Multi-Analyte Molecular Monitoring

Indeterminate GlobeNewswire
MBX Biosciences to Participate in November Investor Conferences
October 20, 2025

MBX Biosciences to Participate in November Investor Conferences

Indeterminate GlobeNewswire
STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek
October 20, 2025

STRATA Skin Sciences Reinforces Market Leadership Following Key Litigation Milestones Against LaserOptek

Indeterminate GlobeNewswire
Arnatar Therapeutics Announces Upcoming Presentations at AASLD The Liver Meeting® 2025 and ASN Kidney Week 2025
October 20, 2025

Arnatar Therapeutics Announces Upcoming Presentations at AASLD The Liver Meeting® 2025 and ASN Kidney Week 2025

Indeterminate GlobeNewswire
Valitor Presents Preclinical Data Demonstrating VLTR-559 Achieves Superior Durability and Sustained Anti-VEGF Activity with a Favorable Safety Profile as a Treatment for Wet AMD
October 20, 2025

Valitor Presents Preclinical Data Demonstrating VLTR-559 Achieves Superior Durability and Sustained Anti-VEGF Activity with a Favorable Safety Profile as a Treatment for Wet AMD

Indeterminate GlobeNewswire
CervoMed to Present at the Emerging Growth Conference
October 20, 2025

CervoMed to Present at the Emerging Growth Conference

Indeterminate GlobeNewswire
BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025
October 20, 2025

BioAtla Presents Promising Interim Data from its Phase 1 Trial with BA3182 in Patients with Treatment Refractory Metastatic Adenocarcinoma at ESMO 2025

Indeterminate GlobeNewswire
Connect Expands Access to Funding Through Curated Venture List
October 20, 2025

Connect Expands Access to Funding Through Curated Venture List

Indeterminate GlobeNewswire
Certara Scientists are Among the Topmost Cited Biopharma Researchers
October 20, 2025

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Indeterminate GlobeNewswire
Judo Bio Presents Data Demonstrating Sustained, Kidney-Selective Gene Silencing Across Species
October 20, 2025

Judo Bio Presents Data Demonstrating Sustained, Kidney-Selective Gene Silencing Across Species

Indeterminate GlobeNewswire
Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025
October 20, 2025

Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025

Indeterminate GlobeNewswire
Two Posters at ESMO Congress 2025 Highlight Immutep’s Focus on Changing Treatment Landscape in First Line Non-Small Cell Lung Cancer
October 20, 2025

Two Posters at ESMO Congress 2025 Highlight Immutep’s Focus on Changing Treatment Landscape in First Line Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverages Across New England Through Atlantic Importing Alliance
October 20, 2025

Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverages Across New England Through Atlantic Importing Alliance

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions